Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular proteins containing sulfhydryl groups represent a broad and non-specific class of molecules characterized by the presence of thiol (-SH) functional groups, primarily found on cysteine residues. These groups are critical for the biological function of a vast array of enzymes and structural proteins, where they participate in catalytic mechanisms, form stabilizing disulfide bridges, and coordinate essential metal ions [1][3]. In pharmacology and toxicology, these proteins are notable as the primary targets for heavy metals such as mercury, lead, and arsenic, which bind with high affinity to sulfhydryl groups, thereby disrupting cellular metabolism and inducing toxicity [2][4]. While certain historical drugs, such as mercurial diuretics, utilized this reactivity to exert their effects, modern drug discovery typically views this category as too broad for targeted therapy due to the high risk of off-target effects. Instead, therapeutic intervention often involves the use of chelating agents like dimercaprol or succimer, which provide exogenous sulfhydryl groups to compete for metal binding and protect endogenous cellular proteins from damage [3][5]. Sources: [1] StatPearls. "Biochemistry, Thiol Groups." NCBI. [2] PubChem. "Mercury (Compound Summary)." National Library of Medicine. [3] StatPearls. "Heavy Metal Toxicity." NCBI. [4] NIH. "Arsenic Toxicity." Agency for Toxic Substances and Disease Registry. [5] LiverTox. "Dimercaprol." National Institute of Diabetes and Digestive and Kidney Diseases.
Drugs or toxins interact with these proteins via covalent modification or coordination of the sulfhydryl (-SH) group on cysteine residues, which can lead to the inhibition of enzymatic activity, alteration of protein conformation, or sequestration of the protein's functional site [1][2].
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular proteins containing sulfhydryl groups.